chrX-70134651-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001551.3(IGBP1):c.317G>A(p.Arg106Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00135 in 1,210,547 control chromosomes in the GnomAD database, including 5 homozygotes. There are 537 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0014 ( 0 hom., 39 hem., cov: 24)
Exomes 𝑓: 0.0013 ( 5 hom. 498 hem. )
Consequence
IGBP1
NM_001551.3 missense
NM_001551.3 missense
Scores
2
3
12
Clinical Significance
Conservation
PhyloP100: 6.78
Genes affected
IGBP1 (HGNC:5461): (immunoglobulin binding protein 1) The proliferation and differentiation of B cells is dependent upon a B-cell antigen receptor (BCR) complex. Binding of antigens to specific B-cell receptors results in a tyrosine phosphorylation reaction through the BCR complex and leads to multiple signal transduction pathways. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009251326).
BP6
Variant X-70134651-G-A is Benign according to our data. Variant chrX-70134651-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 93780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-70134651-G-A is described in Lovd as [Benign].
BS2
High Hemizygotes in GnomAd4 at 39 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGBP1 | NM_001551.3 | c.317G>A | p.Arg106Gln | missense_variant | 3/7 | ENST00000356413.5 | NP_001542.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGBP1 | ENST00000356413.5 | c.317G>A | p.Arg106Gln | missense_variant | 3/7 | 1 | NM_001551.3 | ENSP00000348784.4 | ||
IGBP1 | ENST00000342206.10 | c.317G>A | p.Arg106Gln | missense_variant | 2/6 | 1 | ENSP00000363661.5 |
Frequencies
GnomAD3 genomes AF: 0.00143 AC: 161AN: 112366Hom.: 0 Cov.: 24 AF XY: 0.00113 AC XY: 39AN XY: 34518
GnomAD3 genomes
AF:
AC:
161
AN:
112366
Hom.:
Cov.:
24
AF XY:
AC XY:
39
AN XY:
34518
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00180 AC: 330AN: 183475Hom.: 1 AF XY: 0.00180 AC XY: 122AN XY: 67903
GnomAD3 exomes
AF:
AC:
330
AN:
183475
Hom.:
AF XY:
AC XY:
122
AN XY:
67903
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00134 AC: 1469AN: 1098126Hom.: 5 Cov.: 31 AF XY: 0.00137 AC XY: 498AN XY: 363480
GnomAD4 exome
AF:
AC:
1469
AN:
1098126
Hom.:
Cov.:
31
AF XY:
AC XY:
498
AN XY:
363480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00143 AC: 161AN: 112421Hom.: 0 Cov.: 24 AF XY: 0.00113 AC XY: 39AN XY: 34583
GnomAD4 genome
AF:
AC:
161
AN:
112421
Hom.:
Cov.:
24
AF XY:
AC XY:
39
AN XY:
34583
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
17
ExAC
AF:
AC:
195
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 17, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 30, 2013 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at